StockDriftsStockDriftsTop 41 Catalio Capital Management LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| DNTH | DIANTHUS THERAPEUTICS INC | 9.82% | 560.3K | $47.0M | -14.27%(-93.26K) | $24.59(+283.65%) | 2026-03-31 | |
| BBIO | BRIDGEBIO PHARMA INC | 6.7% | 432.0K | $32.1M | new | $26.75(+188.51%) | 2026-03-31 | |
| ASND | ASCENDIS PHARMA A/S | 6.17% | 129.1K | $29.5M | +8.26%(+9.85K) | $149.40(+83.74%) | 2026-03-31 | |
| BMY | BRISTOL-MYERS SQUIBB CO | 5.33% | 420.7K | $25.5M | -35.06%(-227.17K) | $53.09(+9.50%) | 2026-03-31 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 5.09% | 1.04M | $24.4M | -12.80%(-153.14K) | $12.49(+74.68%) | 2026-03-31 | |
| GILD | GILEAD SCIENCES INC | 4.77% | 163.9K | $22.8M | -43.35%(-125.41K) | $112.53(+16.66%) | 2026-03-31 | |
| TERN | TERNS PHARMACEUTICALS INC | 4.5% | 409.0K | $21.6M | +198.65%(+272.07K) | $38.99(+35.80%) | 2026-03-31 | |
| DFTX | DEFINIUM THERAPEUTICS INC | 4.1% | 1.04M | $19.6M | new | $16.14(+173.71%) | 2026-03-31 | |
| SLNO | SOLENO THERAPEUTICS INC | 4.04% | 577.8K | $19.3M | +60.35%(+217.47K) | $58.83(-9.90%) | 2026-03-31 | |
| BSX | BOSTON SCIENTIFIC CORP | 3.92% | 299.3K | $18.8M | -16.95%(-61.11K) | $98.04(-53.96%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +24.72% | +93.99% |
| Top 20 Holdings Unweighted | +31.38% | +126.79% |
Sign up free to track Catalio Capital Management LP, compare funds side by side, and get alerts the moment positions change.